ARCHIVES

Tivozanib Does Not Improve OS Compared to Sorafenib

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Lines Drawn Over HHS Appropriations.

October 5, 2007

Goodfellow To Lead Gynecologic Oncology Research Team At Ohio State University

January 11, 2013

New Mexico, Missouri, Columbia Next for Review As comprehensive Centers; UCLA Decision In October

September 17, 1976

Friends Of Cancer Research Plan September Launch

August 9, 1996

Senate Approves Supplemental Funds For NIH and FDA.

May 23, 2008